Assuming drug is required, the following results were found.

  • Aubagio (teriflunomide)

    Table of contents FDA warnings This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. Severe liver damage. Aubagio...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Aubagio (teriflunomide)

    Table of contents FDA warnings This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. Severe liver damage. Aubagio...

    https://mschristian.org/index.php/articles/2-uncategorised/8433-aubagio-teriflunomide
  • Tecfidera (dimethyl fumarate)

    It's available in two strengths: 120-mg capsules and 240-mg capsules. Tecfidera generic name Tecfidera is a brand-name drug. It's not currently available as a generic drug. Tecfidera contains the drug dimethyl fumarate. Table of contents What is...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Tecfidera (dimethyl fumarate)

    It's available in two strengths: 120-mg capsules and 240-mg capsules. Tecfidera generic name Tecfidera is a brand-name drug. It's not currently available as a generic drug. Tecfidera contains the drug dimethyl fumarate. Tecfidera side effects Tecfidera...

    https://mschristian.org/index.php/articles/2-uncategorised/8434-tecfidera-dimethyl-fumarate
  • 2021 health plans granted leeway to limit consumers’ benefit from drug coupons

    she was on Humira, made by AbbVie, with an average retail price of roughly $8,600 for two monthly injections. When that drug stopped working for her, Brown's doctor switched her to a different drug. Today she is using another injectable, Skyrizi, also...

    https://mschristian.org/index.php/2021-health-plans-granted-leeway-to-limit-consumers-benefit-from-drug-coupons
  • Pharmacy Benefit Managers and Their Role in Drug Spending - Are they the Good Guys or Bad Guys

    April 2019 Pharmacy benefit manager have a significant behind-the-scenes impact in determining drug costs and patients’ access to medications. Some experts think pharmacy benefit managers need to move their business model away from securing rebates...

    https://mschristian.org/index.php/blog/pharmacy-benefit-managers-and-their-role-in-drug-spending-are-they-the-good-guys-or-bad-guys
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    Drug stocks are tumbling as investors worry about how the coronavirus outbreak may impact their operations. The pandemic, which is halting a great part of the world economy, may also slow clinical trials, drug development, and drug manufacturing. In...

    https://mschristian.org/index.php/blog/my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    Drug stocks are tumbling as investors worry about how the coronavirus outbreak may impact their operations. The pandemic, which is halting a great part of the world economy, may also slow clinical trials, drug development, and drug manufacturing. In...

    https://mschristian.org/index.php/articles/2-uncategorised/10427-my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • Pharmacy Benefit Managers and Their Role in Drug Spending - Are they the Good Guys or Bad Guys

    April 2019 Pharmacy benefit manager have a significant behind-the-scenes impact in determining drug costs and patients’ access to medications. Some experts think pharmacy benefit managers need to move their business model away from securing rebates...

    https://mschristian.org/index.php/articles/2-uncategorised/8865-pharmacy-benefit-managers-and-their-role-in-drug-spending-are-they-the-good-guys-or-bad-guys
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    The electronic drug delivery systems market size is expected to reach around US$ 12.1 Bn by 2026 growing at a CAGR of 8.9% from forecast period 2019 to 2026. LOS ANGELES, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global...

    https://mschristian.org/index.php/articles/2-uncategorised/9073-electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    The electronic drug delivery systems market size is expected to reach around US$ 12.1 Bn by 2026 growing at a CAGR of 8.9% from forecast period 2019 to 2026. LOS ANGELES, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • Top 9 Drugs With the Biggest Price Increases Over 2 Years - Pharmacy Times

    Nine widely-used medications have experienced substantial price surges over the past 2 years, adding $5.1 billion to overall drug spending during this time period, according to a new report. Furthermore, 7 of these 9 drugs were found by the Institute of...

    https://mschristian.org/index.php/blog/top-9-drugs-with-the-biggest-price-increases-over-2-years-pharmacy-times
  • European 'Brain-Boosting' Drug Pushed as Supplement in U.S.

    A supposed "brain-boosting" drug that the FDA previously rejected as a supplement can easily be bought online, and can deliver doses far above normal, researchers found. Although piracetam is approved in Europe to treat cognitive impairment, it was...

    https://mschristian.org/index.php/articles/2-uncategorised/9397-european-brain-boosting-drug-pushed-as-supplement-in-u-s
  • GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Sales Grow - Barron's

    of its appearance at this week’s J.P. Morgan Healthcare Conference, GW Pharmaceuticals, the only company with an approved drug derived from cannabis, says that 2019 sales came in better than expected. The British drug company said on Sunday that its...

    https://mschristian.org/index.php/articles/2-uncategorised/9749-gw-pharmaceuticals-cannabis-based-epilepsy-drug-sales-grow-barron-s
  • How cannabis and cannabis-based drugs harm the brain

    de Medicina MolecularSummary:A new study shows that the long-term use of either cannabis or cannabis-based drugs impairs memory. FULL STORY A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor...

    https://mschristian.org/index.php/blog/how-cannabis-and-cannabis-based-drugs-harm-the-brain
  • Novartis CEO: Malaria drug is biggest hope against coronavirus - SonntagsZeitung - Reuters

    March 29 (Reuters) - Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday....

    https://mschristian.org/index.php/articles/2-uncategorised/10428-novartis-ceo-malaria-drug-is-biggest-hope-against-coronavirus-sonntagszeitung-reuters
  • Stroke drug may also prevent Alzheimer's disease

    Date: Source: Rockefeller University Press Summary: Researchers have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer's disease. The study shows that the genetically engineered protein 3K3A-APC...

    https://mschristian.org/index.php/articles/2-uncategorised/5160-stroke-drug-may-also-prevent-alzheimer-s-disease
  • GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Sales Grow - Barron's

    of its appearance at this week’s J.P. Morgan Healthcare Conference, GW Pharmaceuticals, the only company with an approved drug derived from cannabis, says that 2019 sales came in better than expected. The British drug company said on Sunday that its...

    https://mschristian.org/index.php/blog/gw-pharmaceuticals-cannabis-based-epilepsy-drug-sales-grow-barron-s
  • Humira, Rituxan top list of U.S. drugs with biggest price increases: report - Physician's Weekly

    By Caroline Humer NEW YORK (Reuters) – AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a...

    https://mschristian.org/index.php/blog/humira-rituxan-top-list-of-u-s-drugs-with-biggest-price-increases-report-physician-s-weekly
  • Top 9 Drugs With the Biggest Price Increases Over 2 Years - Pharmacy Times

    Nine widely-used medications have experienced substantial price surges over the past 2 years, adding $5.1 billion to overall drug spending during this time period, according to a new report. Furthermore, 7 of these 9 drugs were found by the Institute of...

    https://mschristian.org/index.php/articles/2-uncategorised/8952-top-9-drugs-with-the-biggest-price-increases-over-2-years-pharmacy-times

Results 1 - 20 of 305